HDFC Life Q1 Review – Higher Reserves Dent Embedded Value Growth; Persistency Trends Stable: Motilal Oswal

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

HDFC Life Insurance Co. saw higher Covid-19 claims and settled gross claims of ~Rs 16 billion (over 70,000) – as claims during the second Covid-19 wave have been three to four times the peak claims seen during the first wave.

The company made an excess mortality reserve of Rs 7 billion towards potential Covid claims, which dented earnings and embedded value operating profit growth.

On the annual premium equivalent front, the individual protection business declined 4% YoY as HDFC Life remains cautious over the near term.

On the other hand, strong trends continued in the non-participating/annuity and credit life segments. Thus, the share of non-par/annuity in the total APE increased to 27%/6%.

Click on the attachment to read the full report:

Motilal Oswal HDFC Life Q1FY22 Result Update.pdf


This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Most Related Links :
usnewsmail Governmental News Finance News

Source link

Back to top button